Tybourne Capital Management Overview
- Investor Type
-
Growth/Expansion
- Status
-
Active
- Professionals
-
7
- Investments
-
38
- Portfolio
-
15
- Exits
-
16
Tybourne Capital Management General Information
Company Description
Founded in 2010, Tybourne Capital Management is a growth equity investment firm based in Hong Kong. The firm seeks to invest in consumer, financial, healthcare, technology, and media sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.tybournecapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Suites 818-822, 8/Floor, Bank of America Tower
- 12 Harcourt Road
- Hong Kong
- Hong Kong
Tybourne Capital Management Investments (38)
Tybourne Capital Management’s most recent investment was a with Z-Alpha Therapeutics. The deal was made on 12-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Z-Alpha Therapeutics | 12-Nov-2026 | Drug Discovery | Generating Revenue | |||
| Bumi Berkah Boga | 24-Sep-2026 | Beverages | Profitable | |||
| Allotera Therapeutics | 08-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Talentio | 19-Mar-2026 | Business/Productivity Software | Generating Revenue | |||
| Asuene | 23-Oct-2025 | Later Stage VC | Other Energy Services | Generating Revenue |
Tybourne Capital Management Exits (16)
Tybourne Capital Management has made a total of 16 exits. Its latest exit was from Zentalis Pharmaceuticals for on 17-Aug-2026. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Zentalis Pharmaceuticals | 17-Aug-2026 | ||
| Forte Biosciences | 10-Apr-2026 | ||
| Upsider | 29-Jul-2025 | ||
| OneSource Specialty Pharma | 24-Jan-2025 | ||
| Lunit | 09-Nov-2023 | Public Investment 2nd Offering |
Tybourne Capital Management Investments by Industry, Year, and Region
Tybourne Capital Management FAQs
-
What is Tybourne Capital Management?
Founded in 2010, Tybourne Capital Management is a growth equity investment firm based in Hong Kong.
-
When was Tybourne Capital Management founded?
Tybourne Capital Management was founded in 2010.
-
Where is Tybourne Capital Management headquartered?
Tybourne Capital Management is headquartered in Hong Kong, Hong Kong.
-
What is Tybourne Capital Management's total asset value?
Tybourne Capital Management has around in total assets under management.
-
How many investments has Tybourne Capital Management made?
Tybourne Capital Management has made 38 investments.
-
What has Tybourne Capital Management invested in?
Tybourne Capital Management has made numerous investments in companies like Z-Alpha Therapeutics, Bumi Berkah Boga, and Allotera Therapeutics within the Drug Discovery and Beverages industries.
-
What has Tybourne Capital Management invested in recently?
Tybourne Capital Management's latest investment was on 12-Nov-2026 in Z-Alpha Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process